Results 41 to 50 of about 112,902 (166)

Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act.

PLoS Medicine
In this Policy Forum piece, Robin Feldman discusses how current legislation contributes to informational deficits around drug patents for biologic drugs in the United States.
Robin Feldman
doaj   +1 more source

Propagandas de medicamentos em revistas femininas

Saúde em Debate
Este artigo tem como objetivo analisar as propagandas de medicamentos veiculadas em revistas femininas de circulação nacional, conforme a RDC 102/00.
Marselle Nobre de Carvalho, José Augusto Cabral de Barros   +1 more
doaj   +2 more sources

Análise da publicidade de medicamentos veiculada em emissoras de rádio do Rio Grande do Sul, Brasil

Cadernos de Saúde Pública
As propagandas de medicamentos veiculadas nas principais rádios do Rio Grande do Sul, Brasil, foram analisadas no período de agosto de 1995 a janeiro de 1996.
Isabela Heineck, Sara Maria Gallina, Tatiane da Silva, Felipe Dal Pizzol, Eloir Paulo Schenkel   +4 more
doaj  

Legislation and drug safety [PDF]

Journal of Clinical Pathology, 1975
openaire   +3 more sources

Impact of the World Trade Organization TRIPS Agreement on the pharmaceutical industry in Thailand

Bulletin of the World Health Organization, 2001
The 1994 World Trade Organization (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) established minimum universal standards in all areas of intellectual property. It is intended to implement these standards globally through
Supakankunti Siripen, Janjaroen Wattana S., Tangphao Oranee, Ratanawijitrasin Sauwakon, Kraipornsak Paitoon, Pradithavanij Pirus   +5 more
doaj  

TERM EXTENSION OF DRUG PATENTS IN RUSSIA (REVIEW OF LEGISLATION AMENDMENTS)

Разработка и регистрация лекарственных средств, 2019
The article describes the procedure of patent term extension to be granted on inventions relating to drugs and of granting a supplementary patent in view of recent amendments introduced in the Civil Code of the Russian Federation.
K. V. Osipov
doaj  

Navigating the nexus between British Columbia’s public consumption and decriminalization policies of illegal drugs

Health Research Policy and Systems
In January 2023, the province of British Columbia (BC) decriminalized the possession of certain illegal drugs for personal use. The province’s primary intent was to reduce the stigma associated with drug use, as well as barriers for people who use drugs (
Farihah Ali, Justine Law, Cayley Russell, Jean-Francois Crépault, João Castel-Branco Goulão, Kurt Lock, Jürgen Rehm   +6 more
doaj   +1 more source

Multisource drug policies in Latin America: survey of 10 countries

Bulletin of the World Health Organization, 2005
Essential drug lists and generic drug policies have been promoted as strategies to improve access to pharmaceuticals and control their rapidly escalating costs.
Homedes Núria, Ugalde Antonio
doaj  

Drug policy reform in South America: Towards a Multiaxial Model of Preventive Regulation

Relaciones Internacionales, 2016
Since the creation of the Union of South American Nations (UNASUR) in 2008, its members evidence an endogenous contradiction in relation to the illegal drug issue.
Nicolás Matías COMINI
doaj  

Innovation, respiration and drug paraphernalia policy: a mixed methods study of crack pipe practice and respiratory harm in England

Harm Reduction Journal
Background Provision of equipment for the purpose of stimulant inhalation is prohibited under UK law. Crack cocaine use is prevalent and rising in England, where the SIPP (safer inhalation pipe provision) study piloted and evaluated a crack equipment and
Magdalena Harris, Cedomir Vuckovic, Caitlynne McGaff, Casey Sharpe, Sujit Rathod, Alexandre Piot, Mat Southwell, Jenny Scott, Vivian Hope, Lucy Platt   +9 more
doaj   +1 more source